Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited to those researching opioid pharmacology,” said Rolling Stone. Nitazene’s ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

Eli Lilly's surging GLP-1 momentum and Johnson & Johnson's diversified strength set up a compelling 2025 showdown for ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

The implantation of electrodes in a patient with obesity has allowed the detection of the trace of tirzepatide in the nucleus ...

We, the Interior and Security Ministers of the G7, together with the European Commissioner for Internal Affairs and Migration and INTERPOL, met on ...

Purdue Pharma L.P. ("Purdue") announced positive preliminary results from a Phase 1 study of tinostamustine in MGMT promoter-unmethylated (uMGMT) glioblastoma (GBM), a form of aggressive brain cancer ...

Pharmaceuticals are entering our waterways through various paths, including unmetabolized drugs excreted by humans into ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

This study presents a case report on pain management and comfort care practices for a 52-year-old male patient with advanced osteosarcoma recurrence and systemic metastasis. The patient presented with ...